Undecaprenyl Diphosphate Synthase Inhibitors: Antibacterial Drug Leads

There is a significant need for new antibiotics due to the rise in drug resistance. Drugs such as methicillin and vancomycin target bacterial cell wall biosynthesis, but methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) have now arisen and are of major concern. Inhibitors acting on new targets in cell wall biosynthesis are thus of particular interest since they might also restore sensitivity to existing drugs, and the cis-prenyl transferase undecaprenyl diphosphate synthase (UPPS), essential for lipid I, lipid II, and thus, peptidoglycan biosynthesis, is one such target. We used 12 UPPS crystal structures to validate virtual screening models and then assayed 100 virtual hits (from 450,000 compounds) against UPPS from S. aureus and Escherichia coli. The most promising inhibitors (IC50 ∼2 μM, Ki ∼300 nM) had activity against MRSA, Listeria monocytogenes, Bacillus anthracis, and a vancomycin-resistant Enterococcus sp. with MIC or IC50 values in the 0.25–4 μg/mL range. Moreover, one compound (1), a rhodanine with close structural similarity to the commercial diabetes drug epalrestat, exhibited good activity as well as a fractional inhibitory concentration index (FICI) of 0.1 with methicillin against the community-acquired MRSA USA300 strain, indicating strong synergism.

[1]  William Sinko,et al.  Antibacterial drug leads targeting isoprenoid biosynthesis , 2012, Proceedings of the National Academy of Sciences.

[2]  F. Lichtenberger,et al.  Abbreviations Used , 1979, Confronting the Bomb.

[3]  Jacob D. Durrant,et al.  Non-Bisphosphonate Inhibitors of Isoprenoid Biosynthesis Identified via Computer-Aided Drug Design , 2011, Chemical biology & drug design.

[4]  R. Macarrón,et al.  The Effect of Triton Concentration on the Activity of Undecaprenyl Pyrophosphate Synthase Inhibitors , 2003, Journal of biomolecular screening.

[5]  J Andrew McCammon,et al.  Farnesyl Diphosphate Synthase Inhibitors from In Silico Screening , 2013, Chemical biology & drug design.

[6]  William Sinko,et al.  Applying Molecular Dynamics Simulations to Identify Rarely Sampled Ligand-bound Conformational States of Undecaprenyl Pyrophosphate Synthase, an Antibacterial Target , 2011, Chemical biology & drug design.

[7]  Rui Zhang,et al.  Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones. , 2008, Bioorganic & medicinal chemistry letters.

[8]  Neil L Kelleher,et al.  Structure determination and interception of biosynthetic intermediates for the plantazolicin class of highly discriminating antibiotics. , 2011, ACS chemical biology.

[9]  E. Oldfield,et al.  Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin. , 2006, Journal of medicinal chemistry.

[10]  Hong Sun,et al.  Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases , 2014, Journal of medicinal chemistry.

[11]  M. Fountoulakis,et al.  Use of Genomics To Identify Bacterial Undecaprenyl Pyrophosphate Synthetase: Cloning, Expression, and Characterization of the Essential uppS Gene , 1999, Journal of bacteriology.

[12]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[13]  M. A. Ramirez,et al.  Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy , 2008, Pharmacotherapy.

[14]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[15]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[16]  J. Pin,et al.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.

[17]  M. Webb A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Woody Sherman,et al.  Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..

[19]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[20]  S. Peukert,et al.  Biophysical Investigation of the Mode of Inhibition of Tetramic Acids, the Allosteric Inhibitors of Undecaprenyl Pyrophosphate Synthase , 2010, Biochemistry.

[21]  Niu Huang,et al.  How to benchmark methods for structure-based virtual screening of large compound libraries. , 2012, Methods in molecular biology.

[22]  J. van Heijenoort Lipid Intermediates in the Biosynthesis of Bacterial Peptidoglycan , 2007, Microbiology and Molecular Biology Reviews.

[23]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[24]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[25]  V. Nizet,et al.  HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis. , 2012, ACS medicinal chemistry letters.

[26]  Christopher T. Walsh,et al.  Antibiotics for Emerging Pathogens , 2009, Science.

[27]  M. Cooper,et al.  Antibiotics in the clinical pipeline in 2011 , 2011, The Journal of Antibiotics.

[28]  E. Oldfield,et al.  Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases , 2007, Proceedings of the National Academy of Sciences.